← All stocks

CRISPR Therapeutics AG

CRSP Net selling

CIK 0001674416 #1275 in the set updated 19 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$16.87M

$5.73M on a plan · $3.89M straight out of an exercise

Sold at will

$7.25M

16 of 26 sales

Net

−$16.87M

−$7.25M against sales at will

By person

8 insiders · 26 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Kulkarni Samarth

Chief Executive Officer

—

$10.76M (9)

−$10.76M

255,501

0.2642%

$14.21M

−17.1%

Prasad Raju

Chief Financial Officer

—

$5.10M (10) scheduled

−$5.10M

14,815

0.0153%

$824.01K

+128.8%

KASINGER JAMES R.

General Counsel and Secretary

—

$645.90K (5)

−$645.90K

94,308

0.0975%

$5.25M

+51.6%

Patel Naimish

Chief Medical Officer

—

$362.60K (2)

−$362.60K

19,357

0.0200%

$1.08M

+3,170%

George Simeon

Director

—

1,730,179

1.79%

$96.23M

+133.7%

Treco Douglas A

Director

—

22,000

0.0228%

$1.22M

+1,000%

Bruno Julianne

Chief Operating Officer

—

10,544

0.0109%

$586.46K

+56.3%

Greene John

Director

—

7,000

0.0072%

$389.34K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Prasad Raju

22 Jan 2026

Chief Financial Officer

Sold after exercise

34,972

$60.19

$2.10M

Prasad Raju

6 Jan 2026

Chief Financial Officer

Sold after exercise

5,763

$60.21

$347.01K

Prasad Raju

6 Jan 2026

Chief Financial Officer

Sold after exercise

5,004

$60.00

$300.24K

Prasad Raju

6 Jan 2026

Chief Financial Officer

Sold after exercise

18,933

$60.18

$1.14M

Show all 26 transactions →

What was left out

Form 4 filings counted 41

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 6

Sales straight out of an exercise 4

Sales at will 16

Transactions with no price 0

Shares from compensation/vesting 343,132

History held since 20 Oct 2016